Due to health issues, this site is no longer maintained and will be shut down shortly. |
Warrant exercisable for one share at $11.50 per share This security was issued by Brookline Capital Acquisition Corp., whose common stock symbol is BCAC.
On 3/18/2022 the company announced a proposed merger with Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology.
$0.55 +0.31 (129.17%)
As of 07/29/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.